Complete remission of psoriasis following bevacizumab therapy for colon cancer.

Primary tabs

field_vote: 
Average: 6 (1 vote)
Publication type: 
Number of included patients: 
References: 
Therapeutic intervention: 
Therapeutic Substance(s): 

Clin Exp Dermatol. 2008 Dec 9.
Complete remission of psoriasis following bevacizumab therapy for colon cancer.
Akman A, Yilmaz E, Mutlu H, Ozdogan M.
Department of Dermatology and Venerology, School of Medicine Antalya, Antalya, Turkey.Summary: 

Bevacizumab is a monoclonal antibody against vascular endothelial
growth factor (VEGF), which is used to treat several cancers.
Currently, experience with anti-VEGF treatment for psoriasis is
limited, and no published reports on this use exist. We describe a
patient with metastatic colon cancer and psoriasis who experienced
complete remission of psoriasis during treatment with bevacizumab and
combination chemotherapy without any other treatment for psoriasis.
These data suggest that bevacizumab may be a promising therapeutic
agent for the treatment of psoriasis.